IE782353L - Ethyl 2-aryl allophanates, medicaments - Google Patents

Ethyl 2-aryl allophanates, medicaments

Info

Publication number
IE782353L
IE782353L IE782353A IE235378A IE782353L IE 782353 L IE782353 L IE 782353L IE 782353 A IE782353 A IE 782353A IE 235378 A IE235378 A IE 235378A IE 782353 L IE782353 L IE 782353L
Authority
IE
Ireland
Prior art keywords
ethyl
medicaments
aryl
allophanates
nervous system
Prior art date
Application number
IE782353A
Other versions
IE47594B1 (en
Original Assignee
Soissonnais Sucrerie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soissonnais Sucrerie filed Critical Soissonnais Sucrerie
Publication of IE782353L publication Critical patent/IE782353L/en
Publication of IE47594B1 publication Critical patent/IE47594B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicaments acting notably on the central nervous system and based on ethyl 2-aryl allophanates. They are based on an ethyl 2-aryl allophanate of the general formula: <IMAGE> in which R1,R2 and R3 may represent hydrogen, chlorine or bromine, a methyl radical (-CH3) or trifluoromethyl radical (-CF3). The medicaments are useful for the treatment of disorders of the central nervous system in humans and animals. [GB2010812A]
IE2353/78A 1977-11-29 1978-11-28 Medicaments acting notably on the central nervous system based on ethyl 2-aryl allophanates IE47594B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7735907A FR2409752A1 (en) 1977-11-29 1977-11-29 MEDICINAL PRODUCT ACTING IN PARTICULAR ON THE CENTRAL NERVOUS SYSTEM BASED ON ARYL-2 ETHYL ALLOPHANATES

Publications (2)

Publication Number Publication Date
IE782353L true IE782353L (en) 1979-05-29
IE47594B1 IE47594B1 (en) 1984-05-02

Family

ID=9198212

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2353/78A IE47594B1 (en) 1977-11-29 1978-11-28 Medicaments acting notably on the central nervous system based on ethyl 2-aryl allophanates

Country Status (10)

Country Link
JP (1) JPS606331B2 (en)
BE (1) BE872163A (en)
CH (1) CH635746A5 (en)
DE (1) DE2851495C2 (en)
FR (1) FR2409752A1 (en)
GB (1) GB2010812B (en)
IE (1) IE47594B1 (en)
IT (1) IT1107673B (en)
LU (1) LU80573A1 (en)
NL (1) NL7811642A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572726B1 (en) * 1984-11-08 1986-12-19 Francaise Sucrerie ISOPROPYL PHENYL-2 ALLOPHANATE, PROCESS FOR THE PRODUCTION THEREOF AND ITS APPLICATION IN THE PHARMACEUTICAL FIELD

Also Published As

Publication number Publication date
JPS606331B2 (en) 1985-02-18
DE2851495A1 (en) 1979-05-31
IT1107673B (en) 1985-11-25
NL7811642A (en) 1979-05-31
BE872163A (en) 1979-05-21
CH635746A5 (en) 1983-04-29
FR2409752B1 (en) 1982-11-12
LU80573A1 (en) 1979-06-15
GB2010812B (en) 1982-05-19
IE47594B1 (en) 1984-05-02
GB2010812A (en) 1979-07-04
FR2409752A1 (en) 1979-06-22
IT7852098A0 (en) 1978-11-28
JPS5492939A (en) 1979-07-23
DE2851495C2 (en) 1982-06-24

Similar Documents

Publication Publication Date Title
ES2065691T3 (en) QUINUCLIDINE DERIVATIVES.
NL300128I1 (en) Substituted isoxysols for the treatment of inflammation.
MY117896A (en) Quinazoline derivatives
AU5799294A (en) Isoxazole-4-carboxamides and hydroxy-alkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
DE69615682D1 (en) N- (1-ALKYL-5-PHENYL-2,3,4,5-TETRAHYDRO-1-H-BENZO [B] [1,5] -DIAZEPIN-3-YL) -ACETAMIDE
DE69101914D1 (en) BRANCHED FRUCTO OLIGOSACCHARIDES, METHOD FOR THE PRODUCTION THEREOF AND USE OF THESE AGENTS.
NO20002702L (en) thienopyrimidine
PT69525A (en) ANIMAL TREATMENT FACILITY, PARTICULARLY EWES
FI970469A (en) Benzimidazole derivatives with dopaminergic activity
DE69500673D1 (en) Medicines for the therapeutic and prophylactic treatment of diseases caused by hyperplasia of the smooth muscle cells
FI901987A0 (en) PROCEDURE FOR THE CONDUCT OF AVAILABILITY.
ES2194102T3 (en) NEW N- (2,4-DIOXO-2,3,4,5-TETRAHIDRO-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
DK1082962T3 (en) Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factors NF- (K) B
IE782353L (en) Ethyl 2-aryl allophanates, medicaments
DE3688397D1 (en) 3- (2-AMINOETHYL) INDOL AND -INDOLINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES.
DE69925160D1 (en) ARYLPIPERIDINE AND ARYL 1,2,5,6-TETRAHYDROPYRIDINAMIDE DERIVATIVES WITH 5HT1A RECEPTOR ACTIVITY
NO951444L (en) Gestagent active 19.11-breed 4-oyster trainer
DE3069265D1 (en) Total synthesis of (1rs, 4sr, 5rs)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo (3.2.1) octane-1-acetic acid and intermediates
NO984651L (en) Use of benzone-offset derivatives for the manufacture of drugs for the treatment of central nervous system diseases
IT1296613B1 (en) DRUG FOR THE TREATMENT OF IRCISM CONTAINING AN ADRENOCORTICOSTEROID.
ID20165A (en) USE OF ACID 2- (3,4-DIMETOXICINAMOIL) AMINOBENZOAT FOR MAKING MEDICINES FOR TREATMENT OR PREVENTION OF RESTENOSIS
DE3069139D1 (en) Total synthesis of (1rs, 4sr, 5rs)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo (3.2.1) octane-1-acetic acid, and intermediates
NO893768D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,7-DIAMINO-1,2,3,4-TETRAHYDRONE AGENCY DERIVATIVES.
AU553493B2 (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
NO880405D0 (en) PROCEDURE FOR THE PREPARATION OF 3-PHENYL-7H-TIAZOLO- / 3,2-B // 1,2,4 / -TIAZINE-7-ONER.